Android app Apple app link

Hemab Therapeutics Holdings Inc. (COAG) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/13/2026 Wedbush David Nierengarten $55.00 $38.85   41.57%
07/13/2026 H.C. Wainwright Emily Bodnar $52.00 $38.03   36.73%
05/26/2026 Wedbush David Nierengarten $42.00 $25.89   62.22%
05/26/2026 Jefferies Maury Raycroft $39.00 $25.89   50.64%
05/26/2026 Goldman Sachs Richard Law $36.00 $25.89   39.05%

Hemab Therapeutics Holdings Inc. FAQ's

Hemab Therapeutics Holdings Inc. has been rated by research analysts at Jefferies, Wedbush, H.C. Wainwright, Evercore ISI, Goldman Sachs in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.